Navigation Links
WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
Date:11/21/2011

85,025$

1,454,920Cost of revenue492,246312,047647,137583,796Gross profit (loss)(403,158)321,194(162,112)871,124Operating expenses:Sales and marketing913,948653,3222,550,1071,378,271Research and development1,900,4172,047,3675,980,3055,086,078General and administrative1,259,2111,248,7734,747,9923,452,727Total operating expenses4,073,5763,949,46213,278,4049,917,076Operating loss(4,476,734)(3,628,268)(13,440,516)(9,045,952)Other income and (expenses):Interest income6,8437,96514,20315,072Interest expense (including excess debt discount of $2,255,074 expensed as interest in the nine months ended September 30, 2011)(240,143)(280)(3,059,370)(1,954)Gain on revaluation of conversion element of Series B redeemable convertible preference shares of subsidiary, net35,615124,473111,227124,473Gain on revaluation of conversion element of convertible promissory notes, net7,525,265--5,912,152--Gain (loss) on revaluation of warrants, net1,064,096(1,665,950)1,363,70314,526Liquidated damages for late S-1 registration(532,161)--(532,161)--Miscellaneous income (expense)214,843(62,703)197,593(135,697)Total other income and (expenses)8,074,358(1,596,495)4,007,34716,420Net income (loss) before provision for income taxes3,597,624(5,224,763)(9,433,169)(9,029,532)Provision for income taxes16,703--(713)--Net income (loss)3,580,921(5,224,763)(9,432,456)(9,029,532)Accretion on Series A and B redeemable convertible preference shares of subsidiary associated with premium(166,773)(79,151)(287,929)(223,464)Accretion on Series B redeemable convertible preference shares of subsidiary associated with bifurcation of conversion element--(428,787)--(428,787)Accretion on Series A-1 convertible preferred stock associated with beneficial conversion feature----(9,250,009)--Series A-1 preferred dividend(191,866)--(266,119)--Net income (loss) attributable to common stockholders

$

3,222,282$

(5,732,701)$

(19,236,513)$

(9,681,783)Net income (loss) pe
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. WaferGen Announces Delay in Reporting of Second Quarter 2011 Results
2. WaferGen Announces $30 Million Financing
3. WaferGen and NuGEN Announce Agreement to Co-Develop Integrated Workflows Using SmartChip System and SPIA® for Single Cell Analysis, FFPE and Next Generation Sequencing
4. WaferGen Announces General Availability of Quick-Turnaround SmartChip Custom Panels
5. WaferGen Names Gary P. Schroth, Ph.D., as New SVP, Genomics Research and Applications
6. WaferGen Corporate Presentation to be Webcast at Rodman and Renshaws 12th Annual Healthcare Conference
7. WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System
8. WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip(TM) Nano-Dispenser with WaferGens SmartChip(TM) High-throughput Real-Time PCR System
9. WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Companys Scientific Advisory Board
10. WaferGen Closes on Private Financings of Approx. $6.2 Million
11. WaferGen to Present at the Rodman and Renshaw Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... CAMBRIDGE, Mass. , July 30, 2015 /PRNewswire/ ... software solutions for the interpretation and analysis of ... Matthew Fischer has joined the company ... Photo - http://photos.prnewswire.com/prnh/20150730/250931 ... astounding capabilities to integrate, interpret, analyze and explore ...
(Date:7/30/2015)... -- According to a new market research ... PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), by ... End Users - Global Forecast to 2020", published by ... 2,107.99 million by 2020 from USD 1,034.93 million in ... Browse more than 75 market ...
(Date:7/30/2015)... SAN DIEGO, July 30, 2015   Senomyx , ... proprietary taste science technologies to discover, develop, and commercialize ... supply industries, today reported financial results for the second ... half of 2015, we remain on track to achieve ... and Chief Executive Officer of the Company. "Since our ...
(Date:7/30/2015)... -- HIGHLIGHTS:Q2 2015 Results (all changes are ... sales were $697 million compared to $701 million in ... 8%, and changes in foreign currency exchange rates decreased ... , By business unit, organic sales growth was ... SAFC Commercial. , Reported diluted EPS was $0.98 ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... Isolate total RNA and protein from cultured cells or tissues , ... from cultured , cells , ... Ambion's new PARIS Kit uses a fast, simple procedure based on , ... from the same experimental sample. The kit also permits separation ...
... SPEX FLUOROLOG spectrofluorometer is capable of detecting sub-picomolar ( ... ing mode FLUOROLOG spectrofluorometer with a 450-W (521 nm) xenon ... in the photon-counting mode. The bandpass was set to 4.0 ... 11020 s, with a single scan and no smoothing. Excita-490 ...
... , , , ... By James Costantin, Ph.D., Yen-Wen Chen, Ph.D., Jinfang Liao, Ph.D., , ... Molecular Devices Corporation, 3280 Whipple Road, Union City, CA 94587., ... Voltage-dependent ion channels represent a, largely untapped portion of the ...
Cached Biology Technology:A Better Way to Isolate RNA AND Protein From the Same Sample 2A Better Way to Isolate RNA AND Protein From the Same Sample 3A Better Way to Isolate RNA AND Protein From the Same Sample 4A Better Way to Isolate RNA AND Protein From the Same Sample 5Sub-Picomolar Fluorescein 2Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 2Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 3Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 4Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 5Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 6Rapid hit confirmation and early hERG liability testing using the IonWorks HT system 7
(Date:7/9/2015)... , July 9, 2015  Unchained Labs just ... its acquisition of Avid Nano. Avid Nano designs, ... (DLS) systems.    Also today, Unchained ... and easiest to use protein sizing system. The ... a protein,s hydrodynamic size, size distribution, aggregation population ...
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/7/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a ... a revised version of one of its first 30 second commercials ... in New York , Chicago ... Francisco metro areas.    , , , ... all the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... from a remote Wisconsin lake have detected what they ... collapse of the lake,s aquatic ecosystem. The finding, ... of researchers led by Stephen Carpenter, an ecologist at ... evidence that radical change in an ecosystem can be ...
... of chemistry and T.C. Pipes endowed chair in micro ... symposium at the 241st Conference of the American Chemical ... and cost-effective nano-material that can be used to significantly ... composites. The symposium featured Lvov,s presentation on the ...
... of scientists, led by researchers at the University of ... new method for discerning the functions of previously uncharacterized ... reveal how gene products interact to bring about cellular ... 29 issue of the journal Cell. It was led ...
Cached Biology News:A tale of 2 lakes: One gives early warning signal for ecosystem collapse 2A tale of 2 lakes: One gives early warning signal for ecosystem collapse 3A tale of 2 lakes: One gives early warning signal for ecosystem collapse 4Louisiana Tech researcher presents on eco-friendly nanotechnology at national conference 2As the worm turns, its secrets are revealed 2
...
... TAMRA isomers are predominantly used for labeling ... for labeling peptides and nucleotides because they ... is often required in the conjugation processes. ... for labeling peptides and proteins. 6-TAMRA is ...
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
Alkali soluble casein is the recommended blot blocking reagent for use with the HisTag Monoclonal Antibody (Novagen) on Western blots....
Biology Products: